EP Patent

EP2699252A2 — Method of drug delivery for pth, pthrp and related peptides

Assigned to 3M Innovative Properties Co · Expires 2014-02-26 · 12y expired

What this patent protects

The present invention provides compositions, devices, methods and processes related to the intradermal delivery of PTHrP and PTHrP analogues, particularly [Glu 22,25 , Leu 23,28,31 , Aib 29 , Lys2 6,30 ]hPTHrP(l-34)NH 2 .

USPTO Abstract

The present invention provides compositions, devices, methods and processes related to the intradermal delivery of PTHrP and PTHrP analogues, particularly [Glu 22,25 , Leu 23,28,31 , Aib 29 , Lys2 6,30 ]hPTHrP(l-34)NH 2 .

Drugs covered by this patent

Patent Metadata

Patent number
EP2699252A2
Jurisdiction
EP
Classification
Expires
2014-02-26
Drug substance claim
No
Drug product claim
No
Assignee
3M Innovative Properties Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.